Evaluation of clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) recruited in China in a phase III, randomized, open-label, first-line study in Asia of gefitinib (G) versus carboplatin/paclitaxel (C/P) (IPASS)
Other conference paper

Full Text

Times Cited
Web of Science3WOS source URL (as at 19/09/2021) Click here for the latest count

Other information
All Author(s) ListWu Y, Mok T, Chu D, Han B, Liu X, Zhang L, Zhou C, Rukazenkov Y, Duffield E, Fukuoka M
Name of Conference45th Annual Meeting of the American-Society-of-Clinical-Oncology
Start Date of Conference29/05/2009
End Date of Conference02/06/2009
Place of ConferenceOrlando
Country/Region of ConferenceUnited States of America
Journal nameJournal of Clinical Oncology
Detailed descriptionorganized by ASCO,
Volume Number27
Issue Number15
PublisherAmerican Society of Clinical Oncology
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2021-20-09 at 00:02